A second
phase 3 study presented Sunday found that adding radiation to hormone therapy, also known
as androgen - deprivation therapy (ADT) in patients with locally advanced or high - risk prostate cancer reduced the seven - year risk of dying by 43 percent compared to treating with hormone therapy alone.